Global High Potency API CDMOs Market OverviewThe global high potency active pharmaceutical ingredient (HPAPI) CDMOs market is ...
U.S. drone manufacturers discuss how additive manufacturing and agile production models are reshaping drone manufacturing.
In the final analysis, smart factory is not defined by a single technology, but by how technologies work together. Machine ...
Track Auro Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit ...
U.S. Ibuprofen API Market to Reach USD 0.22 Billion by 2035 Driven by Rising OTC Pain Medication DemandAustin, May 06, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Ibuprofen API Market size ...
Under President Donald J. Trump’s strong leadership, American manufacturing is surging. After years of career politicians selling out American workers for cheap foreign labor, the American ...
Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of ...
The article introduces an autonomous, AI-driven continuous manufacturing demonstrator that has been developed by the PIPAc consortium (Bruker, Novalix, Alysophil, and De Dietrich Process Systems). It ...
The global contract development and manufacturing organization announced March 23 it completed initial engineering studies for an expanded facility in Charles City, Iowa. Groundbreaking for the new ...
Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 ...
As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results